VAXX
Price:
$0.005
Market Cap:
$633.90K
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin ge...[Read more]
Industry
Biotechnology
IPO Date
2021-11-11
Stock Exchange
OTC
Ticker
VAXX
According to Vaxxinity, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.87M. This represents a change of -94.95% compared to the average of 215.22M of the last 4 quarters.
The mean historical Enterprise Value of Vaxxinity, Inc. over the last ten years is 1.00B. The current 10.87M Enterprise Value has changed 8.32% with respect to the historical average. Over the past ten years (40 quarters), VAXX's Enterprise Value was at its highest in in the December 2020 quarter at 2.07B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
1.00B
Median
569.26M
Minimum
117.77M
Maximum
2.09B
Discovering the peaks and valleys of Vaxxinity, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 2.09B
Minimum Annual Increase = -72.68%
Minimum Annual Enterprise Value = 117.77M
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 117.77M | -25.17% |
| 2022 | 157.39M | -72.35% |
| 2021 | 569.26M | -72.68% |
| 2020 | 2.08B | -0.32% |
The current Enterprise Value of Vaxxinity, Inc. (VAXX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
281.47M
5-year avg
1.00B
10-year avg
1.00B
Vaxxinity, Inc.’s Enterprise Value is greater than PaxMedica, Inc. Common Stock (-4698079.00), less than Strategic Partners A/S (35.45M), greater than NovAccess Global Inc. (2.18M), less than Trevena, Inc. (24.11M), greater than NanoLogix, Inc. (108.80K), less than HEALTHeUNIVERSE, Inc. (0), less than SmileDirectClub, Inc. (778.69M), greater than Evelo Biosciences, Inc. (3.20M), greater than Q BioMed Inc. (4.07M), greater than Infinity Pharmaceuticals, Inc. (-37386946.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -4698079.00 | $12.56K | |
| 35.45M | $3.72M | |
| 2.18M | $6.19K | |
| 24.11M | $10.37K | |
| 108.80K | $11.96K | |
| 0 | $1.18K | |
| 778.69M | $13.39K | |
| 3.20M | $3.80K | |
| 4.07M | $14.51K | |
| -37386946.00 | $9.05K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxxinity, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxxinity, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vaxxinity, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vaxxinity, Inc. (VAXX)?
What is the 3-year average Enterprise Value for Vaxxinity, Inc. (VAXX)?
What is the 5-year average Enterprise Value for Vaxxinity, Inc. (VAXX)?
How does the current Enterprise Value for Vaxxinity, Inc. (VAXX) compare to its historical average?